We are live on ! Find out more
X

Xponance Portfolio holdings

AUM $16.3B
1-Year Est. Return 44.61%
This Fund
S&P 500
This Quarter Est. Return
+6.8%
1 Year Est. Return
+44.61%
3 Year Est. Return
+143.93%
5 Year Est. Return
+195.59%
10 Year Est. Return
+501.04%
AUM
$9.78B
AUM Growth
+$239M
Cap. Flow
-$199M
Cap. Flow %
-2.04%
Top 10 Hldgs %
39.84%
Holding
1,386
New
76
Increased
471
Reduced
763
Closed
70
Avg Time Held
12 quarters
Top 10 Avg Time Held
12 quarters
Top 20 Avg Time Held
10.4 quarters

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$24.4M
2
ORCL icon
Oracle
ORCL
+$10.8M
3
AMZN icon
Amazon
AMZN
+$10.3M
4
COST icon
Costco
COST
+$7.38M
5
XOM icon
ExxonMobil
XOM
+$6.78M

Top Sells

Rank Stock Value
1
UNH icon
UnitedHealth
UNH
+$32.3M
2
ACN icon
Accenture
ACN
+$18.1M
3
ABBV icon
AbbVie
ABBV
+$14.4M
4
TMO icon
Thermo Fisher Scientific
TMO
+$13.3M
5
CAT icon
Caterpillar
CAT
+$10.7M

Sector Composition

Rank Sector Weight
1 Technology 37.1%
2 Consumer Discretionary 11.12%
3 Healthcare 10.76%
4 Financials 10.45%
5 Communication Services 10.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow Held Since
CBOE icon
451
Cboe Global Markets
CBOE
$30.5B
$2.46M 0.03%
14,447
-338
-2% -$60K
2020 Q2
16 quarters
HOLX icon
452
DELISTED
Hologic
HOLX
$2.44M 0.03%
32,899
-120
-0.4% -$8.99K
2020 Q2
16 quarters
MKC icon
453
McCormick & Company Non-Voting
MKC
$12B
$2.42M 0.02%
34,167
-57
-0.2% -$4.15K
2020 Q2
16 quarters
CMS icon
454
CMS Energy
CMS
$20.8B
$2.42M 0.02%
40,675
+760
+2% +$46K
2020 Q2
16 quarters
RPM icon
455
RPM International
RPM
$12.6B
$2.41M 0.02%
22,408
-1,165
-5% -$129K
2020 Q2
16 quarters
BMRN icon
456
BioMarin Pharmaceuticals
BMRN
$10.5B
$2.41M 0.02%
29,307
+11,709
+67% +$975K
2022 Q2
8 quarters
ATO icon
457
Atmos Energy
ATO
$27.6B
$2.39M 0.02%
20,468
-166
-0.8% -$19.3K
2020 Q2
16 quarters
BBY icon
458
Best Buy
BBY
$18.4B
$2.38M 0.02%
28,241
-1,854
-6% -$147K
2020 Q2
16 quarters
WSO icon
459
Watsco Inc
WSO
$12B
$2.38M 0.02%
5,128
-1,035
-17% -$473K
2020 Q2
16 quarters
J icon
460
Jacobs Solutions
J
$16.6B
$2.37M 0.02%
20,493
-172
-0.8% -$20.2K
2020 Q2
16 quarters
NTRS icon
461
Northern Trust
NTRS
$30.6B
$2.36M 0.02%
28,069
-1,017
-3% -$85.4K
2020 Q2
16 quarters
WBD icon
462
DELISTED
Warner Bros
WBD
$2.36M 0.02%
316,739
+1,614
+0.5% +$12.9K
2022 Q2
8 quarters
OC icon
463
Owens Corning
OC
$8.92B
$2.33M 0.02%
13,412
-1,364
-9% -$236K
2020 Q2
16 quarters
MAA icon
464
Mid-America Apartment Communities
MAA
$13.5B
$2.33M 0.02%
16,313
-172
-1% -$23K
2020 Q2
16 quarters
CELH icon
465
Celsius Holdings
CELH
$7.07B
$2.32M 0.02%
40,607
+2,928
+8% +$221K
2022 Q3
7 quarters
SWKS icon
466
Skyworks Solutions
SWKS
$11.5B
$2.31M 0.02%
21,641
-107
-0.5% -$10.5K
2020 Q2
16 quarters
MKL icon
467
Markel Group
MKL
$22.2B
$2.31M 0.02%
1,463
+201
+16% +$312K
2021 Q2
12 quarters
TXRH icon
468
Texas Roadhouse
TXRH
$10.6B
$2.3M 0.02%
13,404
-758
-5% -$124K
2020 Q2
16 quarters
ELF icon
469
e.l.f. Beauty
ELF
$6.38B
$2.29M 0.02%
10,844
+2,963
+38% +$527K
2023 Q1
5 quarters
CE icon
470
Celanese
CE
$4.91B
$2.28M 0.02%
16,882
+3,592
+27% +$549K
2020 Q2
16 quarters
PKG icon
471
Packaging Corp of America
PKG
$20.6B
$2.26M 0.02%
12,356
+47
+0.4% +$8.55K
2020 Q2
16 quarters
CFG icon
472
Citizens Financial Group
CFG
$26.7B
$2.25M 0.02%
62,449
-2,666
-4% -$93K
2020 Q2
16 quarters
DGX icon
473
Quest Diagnostics
DGX
$25.4B
$2.24M 0.02%
16,390
-1,057
-6% -$145K
2020 Q2
16 quarters
UTHR icon
474
United Therapeutics
UTHR
$23.3B
$2.19M 0.02%
6,879
-838
-11% -$222K
2020 Q2
16 quarters
VRSN icon
475
VeriSign
VRSN
$27.3B
$2.19M 0.02%
12,295
-97
-0.8% -$17.3K
2020 Q2
16 quarters
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
MFG
Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return
PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
BS
Banco Santander Madrid, Spain $16.1B AUM 35.02% 1-Year Est. Return
BBVA
Banco Bilbao Vizcaya Argentaria Madrid, Spain $16.1B AUM 40.83% 1-Year Est. Return
NMO
Newlands Management Operations Dallas, Texas $16.6B AUM 3.91% 1-Year Est. Return
PAS
Park Avenue Securities New York $16B AUM 26.77% 1-Year Est. Return

Xponance's Q2 2024 Portfolio in Review

As of Q2 2024, Xponance held 1,386 positions worth $9.78B, up 2.5% from $9.54B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Xponance's Q2 2024 filing shows 76 new, 471 increased, 763 reduced and 70 closed positions. Its largest new stake was GE Vernova: 36,466 shares worth $6.25M. The largest sale was UnitedHealth, an estimated $32.3M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 34% a quarter earlier, followed by Consumer Discretionary and Healthcare.

  • Xponance's largest Q2 2024 buy was GE Vernova: 36,466 shares worth $6.25M.
  • Xponance added most to Merck in Q2 2024, an estimated $24.4M increase.
  • Xponance's biggest Q2 2024 reduction was UnitedHealth, cutting an estimated $32.3M.
  • Xponance fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $8.15M.
  • Xponance's ten largest holdings make up 40% of its $9.78B portfolio in Q2 2024.
  • Xponance opened 76 new positions and closed 70 in Q2 2024.
  • Xponance's portfolio value rose 2.5% quarter-over-quarter to $9.78B.

Based on Xponance's 13F filing for Q2 2024, filed 14 Aug 2024.